Saber AminYavari, PhD, founded Preimure (www.preimure.com), a spin-off of the University Medical Center Utrecht in the Netherlands, to develop an ultra-tunable and biostable antibacterial coating aimed at revolutionizing infection prevention in orthopedic and medical implants. The coating releases antibacterial agents in a controlled, tunable manner over an extended period of at least six weeks.